Inside Aesthetics Ep 219 The Tox Talks (Chapter 6): Letybo/Letibotulinum Toxin | Professor Syed Haq
Episode 219 hosts Professor Syed Haq (Cosmetic Physician from London, UK)
Syed divides his time between preventative medicine & aesthetics. He has previously been an advisory board member for Ipsen, Allergan Aesthetics and is a Hugel Aesthetics KOL for Letybo.
In this mini series 'The Tox Talks', we feature expert injectors who have significant experience in using botulinum toxins. These episodes explore our guests experiences using particular brands, the evolution of their injecting techniques and we get special insights into the subtle nuances of getting the best out of toxins.
In chapter 6 we focus on a newly-launched product called Letybo (Letibotulinum Toxin A), a toxin produced by Hugel Aesthetics. Letybo is also known as Botulax and has been used in the Asian market since 2009.
00:00 Introduction 01:04 Tox Talks Chapter Six Introduction 02:15 New Toxin Release Discussion 03:33 Meet Professor Syed Haq 04:55 Professional Background and Research 09:10 Interest in Skin Aging and Inflammation 10:59 Role as Key Opinion Leader Explained 13:31 Evolution of Neurotoxins in Aesthetics 18:27 Manufacturing and Safety Considerations 21:18 Letybo and Botulax Overview 26:25 Clinical Trial Evidence and Comparisons 30:08 Practical Use and Patient Selection 33:29 Injection Techniques and Variability 36:15 Common Causes of Treatment Differences 38:45 Injection Depth and Needle Choice 40:13 Placebo and Nocebo Effects 41:37 Dosing Strategies and Clinical Patterns 42:46 Frontalis and Lower Face Treatment Doses 47:06 Managing Patient Expectations 48:53 Explaining New Toxins to Patients 52:09 Pricing and Business Considerations 61:45 Unit vs Area Pricing Debate 64:07 Clinical Practice Preferences 68:49 Final Thoughts and Wrap Up